Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis

Overview of attention for article published in Frontiers in Pharmacology, January 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 16 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,328 followers.

RT @FrontPharmacol: New Research: Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast canc…

30 Jan 2023

Reply Repost Favourite

New Research: Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis https://t.co/MBzDiUuEbA #pharmacology

30 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.